methylprednisolone and Acquired Form of Epidermolysis Bullosa

methylprednisolone has been researched along with Acquired Form of Epidermolysis Bullosa in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beckmann, T; Boehncke, WH; Hänsel, M; Hellberg, L; Holdorf, K; Kirchner, T; Laskay, T; Ludwig, RJ; Möckel, N; Recke, A; Samavedam, UKSRL; Schmidt, E; Solbach, W; Steinhorst, K; Zillikens, D1
Borradori, L; Simon, D; Simon, HU1
Kim, JH; Kim, SC; Kim, YH1
Ashida, A; Fukuda, S; Hashimoto, T; Kiniwa, Y; Kitoh, R; Ohashi, A; Okuyama, R1
Cetkovská, P; Pizinger, K; Skálová, A1
Aclimandos, WA1

Other Studies

6 other study(ies) available for methylprednisolone and Acquired Form of Epidermolysis Bullosa

ArticleYear
Methylprednisolone blocks autoantibody-induced tissue damage in experimental models of bullous pemphigoid and epidermolysis bullosa acquisita through inhibition of neutrophil activation.
    The Journal of investigative dermatology, 2013, Volume: 133, Issue:10

    Topics: Adult; Animals; Antigen-Antibody Complex; Autoantibodies; Butadienes; Dermis; Disease Models, Animal; Enzyme Inhibitors; Epidermal Cells; Epidermis; Epidermolysis Bullosa Acquisita; Glucocorticoids; Humans; Imidazoles; MAP Kinase Signaling System; Methylprednisolone; Mice; Mice, Inbred C57BL; Neutrophils; Nitriles; Pemphigoid, Bullous; Pyridines; Reactive Oxygen Species; Respiratory Burst

2013
Glucocorticoids in autoimmune bullous diseases: are neutrophils the key cellular target?
    The Journal of investigative dermatology, 2013, Volume: 133, Issue:10

    Topics: Animals; Autoantibodies; Epidermolysis Bullosa Acquisita; Humans; Methylprednisolone; Neutrophils; Pemphigoid, Bullous

2013
Epidermolysis bullosa acquisita: a retrospective clinical analysis of 30 cases.
    Acta dermato-venereologica, 2011, Volume: 91, Issue:3

    Topics: Adult; Aged; Colchicine; Dapsone; Drug Therapy, Combination; Epidermolysis Bullosa Acquisita; Female; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Methylprednisolone; Middle Aged; Remission Induction; Republic of Korea; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult

2011
A case of epidermolysis bullosa acquisita associated with laryngeal stenosis.
    Acta dermato-venereologica, 2012, Volume: 92, Issue:1

    Topics: Aged; Anti-Inflammatory Agents; Colchicine; Epidermolysis Bullosa Acquisita; Female; Humans; Laryngostenosis; Methylprednisolone; Mouth Mucosa; Prednisolone; Tubulin Modulators

2012
Epidermolysis bullosa acquisita-like reaction associated with penicillamine therapy for sclerodermatous graft-versus-host disease.
    Journal of the American Academy of Dermatology, 2003, Volume: 49, Issue:6

    Topics: Bone Marrow Transplantation; Cyclosporine; Epidermolysis Bullosa Acquisita; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Penicillamine; Scleroderma, Systemic

2003
Corneal perforation as a complication of epidermolysis bullosa acquisita.
    Eye (London, England), 1995, Volume: 9 ( Pt 5)

    Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Corneal Diseases; Epidermolysis Bullosa Acquisita; Female; Humans; Methylprednisolone; Mydriatics; Rupture, Spontaneous; Sarcoidosis

1995